T. Rowe Price Associates’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-164,735
| Closed | -$1.95M | – | 3046 |
|
|
2024
Q4 | $1.95M | Sell |
164,735
-160,933
| -49% | -$1.9M | ﹤0.01% | 1655 |
|
|
2024
Q3 | $6.72M | Buy |
325,668
+23,482
| +8% | +$484K | ﹤0.01% | 1221 |
|
|
2024
Q2 | $13.7M | Buy |
302,186
+109,691
| +57% | +$4.96M | ﹤0.01% | 1049 |
|
|
2024
Q1 | $7.55M | Buy |
+192,495
| New | +$7.55M | ﹤0.01% | 1151 |
|
|
2023
Q1 | – | Sell |
-1,877
| Closed | -$6K | – | 2929 |
|
|
2022
Q4 | $6K | Hold |
1,877
| – | – | ﹤0.01% | 2911 |
|
|
2022
Q3 | $10K | Hold |
1,877
| – | – | ﹤0.01% | 2931 |
|
|
2022
Q2 | $14K | Buy |
1,877
+330
| +21% | +$2.46K | ﹤0.01% | 2933 |
|
|
2022
Q1 | $25K | Buy |
1,547
+553
| +56% | +$8.94K | ﹤0.01% | 2947 |
|
|
2021
Q4 | $18K | Buy |
994
+47
| +5% | +$851 | ﹤0.01% | 2961 |
|
|
2021
Q3 | $29K | Hold |
947
| – | – | ﹤0.01% | 2917 |
|
|
2021
Q2 | $52K | Buy |
947
+566
| +149% | +$31.1K | ﹤0.01% | 2890 |
|
|
2021
Q1 | $23K | Buy |
381
+19
| +5% | +$1.15K | ﹤0.01% | 2832 |
|
|
2020
Q4 | $14K | Sell |
362
-3,456
| -91% | -$134K | ﹤0.01% | 2658 |
|
|
2020
Q3 | $206K | Hold |
3,818
| – | – | ﹤0.01% | 2406 |
|
|
2020
Q2 | $961K | Buy |
3,818
+26
| +0.7% | +$6.54K | ﹤0.01% | 1798 |
|
|
2020
Q1 | $596K | Buy |
3,792
+97
| +3% | +$15.2K | ﹤0.01% | 1900 |
|
|
2019
Q4 | $605K | Sell |
3,695
-162
| -4% | -$26.5K | ﹤0.01% | 2083 |
|
|
2019
Q3 | $563K | Buy |
3,857
+663
| +21% | +$96.8K | ﹤0.01% | 2041 |
|
|
2019
Q2 | $664K | Buy |
3,194
+461
| +17% | +$95.8K | ﹤0.01% | 2001 |
|
|
2019
Q1 | $570K | Sell |
2,733
-283
| -9% | -$59K | ﹤0.01% | 2070 |
|
|
2018
Q4 | $528K | Buy |
3,016
+613
| +26% | +$107K | ﹤0.01% | 2051 |
|
|
2018
Q3 | $544K | Buy |
2,403
+10
| +0.4% | +$2.26K | ﹤0.01% | 2114 |
|
|
2018
Q2 | $363K | Sell |
2,393
-625
| -21% | -$94.8K | ﹤0.01% | 2269 |
|
|
2018
Q1 | $552K | Buy |
3,018
+757
| +33% | +$138K | ﹤0.01% | 2042 |
|
|
2017
Q4 | $482K | Buy |
2,261
+1,677
| +287% | +$358K | ﹤0.01% | 2088 |
|
|
2017
Q3 | $125K | Buy |
+584
| New | +$125K | ﹤0.01% | 2459 |
|